Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development and Validation of a Machine-Learning Model to Predict Early Recurrence of Intrahepatic Cholangiocarcinoma.
Alaimo L, Lima HA, Moazzam Z, Endo Y, Yang J, Ruzzenente A, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Shen F, Cauchy F, Koerkamp BG, Endo I, Kitago M, Pawlik TM. Alaimo L, et al. Among authors: kitago m. Ann Surg Oncol. 2023 Sep;30(9):5406-5415. doi: 10.1245/s10434-023-13636-8. Epub 2023 May 20. Ann Surg Oncol. 2023. PMID: 37210452 Clinical Trial.
Efficacy and safety of preoperative 5-fluorouracil, cisplatin, and mitomycin C in combination with radiotherapy in patients with resectable and borderline resectable pancreatic cancer: a long-term follow-up study.
Endo Y, Kitago M, Aiura K, Shinoda M, Yagi H, Abe Y, Oshima G, Hori S, Nakano Y, Itano O, Fukada J, Masugi Y, Kitagawa Y. Endo Y, et al. Among authors: kitago m. World J Surg Oncol. 2019 Aug 16;17(1):145. doi: 10.1186/s12957-019-1687-4. World J Surg Oncol. 2019. PMID: 31420046 Free PMC article.
Clinicopathological impacts of DNA methylation alterations on pancreatic ductal adenocarcinoma: prediction of early recurrence based on genome-wide DNA methylation profiling.
Endo Y, Fujimoto M, Ito N, Takahashi Y, Kitago M, Gotoh M, Hiraoka N, Yoshida T, Kitagawa Y, Kanai Y, Arai E. Endo Y, et al. Among authors: kitago m. J Cancer Res Clin Oncol. 2021 May;147(5):1341-1354. doi: 10.1007/s00432-021-03541-6. Epub 2021 Feb 26. J Cancer Res Clin Oncol. 2021. PMID: 33635431 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 36097298
A Novel Online Calculator to Predict Risk of Microvascular Invasion in the Preoperative Setting for Hepatocellular Carcinoma Patients Undergoing Curative-Intent Surgery.
Endo Y, Alaimo L, Lima HA, Moazzam Z, Ratti F, Marques HP, Soubrane O, Lam V, Kitago M, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM. Endo Y, et al. Among authors: kitago m. Ann Surg Oncol. 2023 Feb;30(2):725-733. doi: 10.1245/s10434-022-12494-0. Epub 2022 Sep 14. Ann Surg Oncol. 2023. PMID: 36103014
Tumor Burden Score and Serum Alpha-fetoprotein Subclassify Intermediate-Stage Hepatocellular Carcinoma.
Lima HA, Endo Y, Alaimo L, Moazzam Z, Munir MM, Shaikh C, Resende V, Guglielmi A, Marques HP, Cauchy F, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Hugh T, Endo I, Kitago M, Shen F, Pawlik TM. Lima HA, et al. Among authors: kitago m. J Gastrointest Surg. 2022 Dec;26(12):2512-2521. doi: 10.1007/s11605-022-05469-9. Epub 2022 Sep 28. J Gastrointest Surg. 2022. PMID: 36171471
TAC score better predicts survival than the BCLC following resection of hepatocellular carcinoma.
Lima HA, Endo Y, Moazzam Z, Alaimo L, Shaikh C, Munir MM, Resende V, Guglielmi A, Marques HP, Cauchy F, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Endo I, Kitago M, Shen F, Pawlik TM. Lima HA, et al. Among authors: kitago m. J Surg Oncol. 2023 Mar;127(3):374-384. doi: 10.1002/jso.27116. Epub 2022 Oct 4. J Surg Oncol. 2023. PMID: 36194039 Free PMC article.
219 results